Preprint · CC-BY
via OpenAlex
mTOR Inhibition via Low-dose, Pulsed Rapamycin with Intraovarian Condensed Platelet Cytokines: An Individualized Protocol to Recover Diminished Reserve
Eric Scott Sills, Conor Harrity, Samuel H. Wood, Seang Lin Tan
Preprints.org · 2023 · ▲ 1 citations
Deregulated nutrient-sensing
Stem-cell exhaustion
Chronic inflammation
Rapamycin / mTOR inhibition
Human
Abstract
No major breakthroughs have entered mainstream clinical fertility practice since egg donation and intracytoplasmic sperm injection decades ago, and oocyte deficits secondary to advanced age continue as the main manifestation of diminished ovarian reserve. In the meantime, several unproven IVF ‘accessories’ have emerged including so-called ovarian rejuvenation which entails placing fresh autologous platelet-rich plasma (PRP) directly into ovarian tissue. Among cellular responses attributed to this intervention are reduced oxidative stress, slowed apoptosis, and improved metabolism. Besides impacting the existing follicle pool, platelet growth factors might also facilitate de novo oocyte recruitment by specified gene upregulation targeting uncommitted ovarian stem cells. Because disordered activity at mechanistic target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR) has been shown to exacerbate or accelerate ovarian aging, PRP-discharged plasma cytokines combined with mTOR suppression by pulsed/cyclic rapamycin represents a novel fusion technique to enhance ovarian function. While beneficial effects have already been observed experimentally in oocytes and embryos with mTOR inhibition alone, this is the first discussion of intraovarian platelet cytokines followed by low-dose, phased rapamycin. For refractory cases, this investigational, tailored approach could amplify or sustain ovarian capacity sufficient to permit retrieval of competent oocytes via distinct but complementary pathways—thus reducing dependency on oocyte donation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.20944/preprints202306.1357.v1
- Canonical
- link ↗
- Fetched
- 2026-10-07 MST
Cite this
APA
Sills, E.S., Harrity, C., Wood, S.H., & Tan, S.L. (2023). mTOR Inhibition via Low-dose, Pulsed Rapamycin with Intraovarian Condensed Platelet Cytokines: An Individualized Protocol to Recover Diminished Reserve. <em>Preprints.org</em>. https://doi.org/10.20944/preprints202306.1357.v1
Vancouver
Sills ES, Harrity C, Wood SH, Tan SL. mTOR Inhibition via Low-dose, Pulsed Rapamycin with Intraovarian Condensed Platelet Cytokines: An Individualized Protocol to Recover Diminished Reserve. Preprints.org. 2023. doi:10.20944/preprints202306.1357.v1.
BibTeX
@unpublished{eric2023mTORIn,
title = {mTOR Inhibition via Low-dose, Pulsed Rapamycin with Intraovarian Condensed Platelet Cytokines: An Individualized Protocol to Recover Diminished Reserve},
author = {Eric Scott Sills and Conor Harrity and Samuel H. Wood and Seang Lin Tan},
journal = {Preprints.org},
year = {2023},
doi = {10.20944/preprints202306.1357.v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Personalized Medicine 2023
Open access · CC-BY
mTOR Inhibition via Low-Dose, Pulsed Rapamycin with Intraovarian Condensed Platelet Cytokines: An Individualized Protocol to Recover Diminished Reserve?
medRxiv 2023
Preprint · CC-BY
Evaluating the life-extending potential and safety profile of rapamycin: a Mendelian Randomization study of the mTOR pathway
Preprints.org 2025
Preprint · CC-BY
Metabolically Active but Dysfunctional: The Role of Senescence and SASP in Metabolic Diseases
F1000Research 2019
Open access · CC-BY
mTOR as a central regulator of lifespan and aging
Scientific Reports 2018
Open access · CC-BY
Premature recruitment of oocyte pool and increased mTOR activity in Fmr1 knockout mice and reversal of phenotype with rapamycin
Aging Cell 2013
Open access · CC-BY